| Bioactivity | Sp-cGMPS is an activator of cGMP-dependent protein kinases (PKGs). Sp-cGMPS can be used in cardiovascular disease-related research[1]. |
| CAS | 86562-10-9 |
| Formula | C10H12N5O6PS |
| Molar Mass | 361.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Archer SL,et al. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7583-7. [2]. Butt E, et al. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br J Pharmacol. 1995 Dec;116(8):3110-6. |
Sp-cGMPS
CAS: 86562-10-9 F: C10H12N5O6PS W: 361.27
Sp-cGMPS is an activator of cGMP-dependent protein kinases (PKGs). Sp-cGMPS can be used in cardiovascular disease-relate
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.